2158 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 44 | next ยป
Genei
Gene descriptioni x
Evidencei x
Tissuei
Braini
Single celli
Subcelli
Canceri
Bloodi
Cell linei
Struct & Inti
Prognostic p-valuei x
BMAL2Basic helix-loop-helix ARNT like 2
Pancreatic Adenocarcinoma (TCGA): 4.82e-8
Lung Adenocarcinoma (TCGA): 3.26e-6
Pancreatic Adenocarcinoma (validation): 4.50e-4
Lung Adenocarcinoma (validation): 6.58e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 7.08e-4
CHEK1Checkpoint kinase 1
Liver Hepatocellular Carcinoma (TCGA): 7.39e-8
Pancreatic Adenocarcinoma (TCGA): 7.53e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.73e-6
Liver Hepatocellular Carcinoma (validation): 4.26e-5
Lung Adenocarcinoma (TCGA): 6.32e-5
Lung Adenocarcinoma (validation): 5.44e-4
MRPL3Mitochondrial ribosomal protein L3
Liver Hepatocellular Carcinoma (TCGA): 1.27e-7
Pancreatic Adenocarcinoma (TCGA): 1.80e-7
Liver Hepatocellular Carcinoma (validation): 1.16e-5
Lung Adenocarcinoma (validation): 1.28e-4
KIF4AKinesin family member 4A
Liver Hepatocellular Carcinoma (validation): 2.27e-12
Kidney Renal Clear Cell Carcinoma (TCGA): 6.45e-8
Liver Hepatocellular Carcinoma (TCGA): 2.45e-7
Pancreatic Adenocarcinoma (TCGA): 3.09e-7
Kidney Renal Clear Cell Carcinoma (validation): 4.23e-7
Lung Adenocarcinoma (TCGA): 1.27e-4
Lung Adenocarcinoma (validation): 2.04e-4
INSIG2Insulin induced gene 2
Pancreatic Adenocarcinoma (TCGA): 1.16e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 3.05e-6
Kidney Renal Clear Cell Carcinoma (validation): 7.30e-6
SPDL1Spindle apparatus coiled-coil protein 1
Lung Adenocarcinoma (TCGA): 1.14e-6
Pancreatic Adenocarcinoma (TCGA): 1.45e-6
Liver Hepatocellular Carcinoma (TCGA): 1.17e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 8.68e-5
Pancreatic Adenocarcinoma (validation): 5.46e-4
NCAPGNon-SMC condensin I complex subunit G
Liver Hepatocellular Carcinoma (validation): 4.43e-9
Pancreatic Adenocarcinoma (TCGA): 1.78e-6
Liver Hepatocellular Carcinoma (TCGA): 2.99e-5
Lung Adenocarcinoma (TCGA): 5.70e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 6.47e-5
Lung Adenocarcinoma (validation): 4.99e-4
Kidney Renal Clear Cell Carcinoma (validation): 5.23e-4
GMPSGuanine monophosphate synthase
Liver Hepatocellular Carcinoma (validation): 2.29e-7
Liver Hepatocellular Carcinoma (TCGA): 6.63e-7
Pancreatic Adenocarcinoma (TCGA): 1.80e-6
Lung Adenocarcinoma (TCGA): 3.44e-5
Lung Adenocarcinoma (validation): 6.08e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.65e-4
Thyroid Carcinoma (TCGA): 8.47e-4
TYMSThymidylate synthetase
Liver Hepatocellular Carcinoma (validation): 1.00e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 1.58e-6
Lung Adenocarcinoma (TCGA): 1.80e-6
Pancreatic Adenocarcinoma (TCGA): 1.81e-6
Liver Hepatocellular Carcinoma (TCGA): 6.02e-5
KNSTRNKinetochore localized astrin (SPAG5) binding protein
Lung Adenocarcinoma (TCGA): 1.42e-7
Pancreatic Adenocarcinoma (TCGA): 1.83e-6
Liver Hepatocellular Carcinoma (TCGA): 5.39e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.49e-4
Kidney Chromophobe (TCGA): 1.98e-4
Lung Adenocarcinoma (validation): 5.97e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 8.83e-4
ANLNAnillin, actin binding protein
Liver Hepatocellular Carcinoma (validation): 2.40e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.71e-9
Lung Adenocarcinoma (TCGA): 9.34e-8
Pancreatic Adenocarcinoma (TCGA): 1.84e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.73e-6
Liver Hepatocellular Carcinoma (TCGA): 9.35e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.27e-4
Lung Adenocarcinoma (validation): 1.34e-4
Kidney Chromophobe (TCGA): 6.88e-4
RAB11ARAB11A, member RAS oncogene family
Kidney Renal Clear Cell Carcinoma (TCGA): 1.60e-9
Pancreatic Adenocarcinoma (TCGA): 3.37e-6
Kidney Renal Clear Cell Carcinoma (validation): 3.32e-5
Liver Hepatocellular Carcinoma (validation): 1.83e-4
KCMF1Potassium channel modulatory factor 1
Pancreatic Adenocarcinoma (TCGA): 6.14e-6
Liver Hepatocellular Carcinoma (validation): 1.07e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.36e-5
Liver Hepatocellular Carcinoma (TCGA): 4.57e-4
GPR87G protein-coupled receptor 87
Pancreatic Adenocarcinoma (TCGA): 6.81e-6
Pancreatic Adenocarcinoma (validation): 3.05e-4
AQP7Aquaporin 7
Pancreatic Adenocarcinoma (TCGA): 7.06e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.07e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.33e-4
Lung Adenocarcinoma (validation): 9.56e-4
NME1-NME2NME1-NME2 readthrough
Kidney Renal Clear Cell Carcinoma (validation): 4.28e-9
Pancreatic Adenocarcinoma (TCGA): 7.20e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 5.32e-4
TUBA1CTubulin alpha 1c
Liver Hepatocellular Carcinoma (TCGA): 4.74e-10
Liver Hepatocellular Carcinoma (validation): 4.36e-6
Pancreatic Adenocarcinoma (TCGA): 7.84e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.62e-5
Lung Adenocarcinoma (validation): 3.05e-5
Bladder Urothelial Carcinoma (TCGA): 1.05e-4
Glioblastoma Multiforme (validation): 1.09e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 1.25e-4
Lung Adenocarcinoma (TCGA): 2.50e-4
KIF20AKinesin family member 20A
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.32e-12
Kidney Renal Clear Cell Carcinoma (TCGA): 1.12e-11
Liver Hepatocellular Carcinoma (TCGA): 4.68e-9
Liver Hepatocellular Carcinoma (validation): 5.05e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.58e-6
Pancreatic Adenocarcinoma (TCGA): 7.84e-6
Lung Adenocarcinoma (TCGA): 7.90e-6
Lung Adenocarcinoma (validation): 1.36e-5
Kidney Chromophobe (TCGA): 4.65e-5
ASF1BAnti-silencing function 1B histone chaperone
Liver Hepatocellular Carcinoma (validation): 1.21e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.29e-9
Kidney Chromophobe (TCGA): 8.56e-7
Kidney Renal Clear Cell Carcinoma (validation): 1.59e-6
Pancreatic Adenocarcinoma (TCGA): 1.09e-5
Lung Adenocarcinoma (validation): 3.22e-5
Lung Adenocarcinoma (TCGA): 1.50e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 1.57e-4
Stomach Adenocarcinoma (TCGA): 4.66e-4
Liver Hepatocellular Carcinoma (TCGA): 5.76e-4
Lung Squamous Cell Carcinoma (TCGA): 9.62e-4
INPP5KInositol polyphosphate-5-phosphatase K
Kidney Renal Clear Cell Carcinoma (TCGA): 7.94e-7
Pancreatic Adenocarcinoma (TCGA): 1.12e-5
Kidney Renal Clear Cell Carcinoma (validation): 5.63e-5
Pancreatic Adenocarcinoma (validation): 8.55e-4
METTL5Methyltransferase 5, N6-adenosine
Liver Hepatocellular Carcinoma (validation): 1.30e-6
Liver Hepatocellular Carcinoma (TCGA): 1.72e-6
Lung Adenocarcinoma (TCGA): 6.52e-6
Pancreatic Adenocarcinoma (TCGA): 1.33e-5
Breast Invasive Carcinoma (TCGA): 2.04e-4
B3GNT8UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8
Pancreatic Adenocarcinoma (TCGA): 1.59e-5
Pancreatic Adenocarcinoma (validation): 3.07e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.01e-4
INCENPInner centromere protein
Pancreatic Adenocarcinoma (TCGA): 1.67e-5
Kidney Chromophobe (TCGA): 1.26e-4
Liver Hepatocellular Carcinoma (validation): 1.66e-4
Lung Adenocarcinoma (validation): 2.13e-4
Liver Hepatocellular Carcinoma (TCGA): 3.14e-4
Lung Adenocarcinoma (TCGA): 6.11e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 8.75e-4
KIF23Kinesin family member 23
Kidney Renal Clear Cell Carcinoma (TCGA): 4.28e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.42e-7
Liver Hepatocellular Carcinoma (validation): 2.97e-7
Kidney Renal Clear Cell Carcinoma (validation): 3.55e-7
Lung Adenocarcinoma (TCGA): 1.19e-6
Liver Hepatocellular Carcinoma (TCGA): 4.63e-6
Pancreatic Adenocarcinoma (TCGA): 1.67e-5
Kidney Chromophobe (TCGA): 1.64e-4
Lung Adenocarcinoma (validation): 1.82e-4
GTSE1G2 and S-phase expressed 1
Kidney Renal Clear Cell Carcinoma (TCGA): 9.24e-9
Liver Hepatocellular Carcinoma (TCGA): 3.24e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.24e-7
Liver Hepatocellular Carcinoma (validation): 1.27e-6
Lung Adenocarcinoma (TCGA): 9.34e-6
Pancreatic Adenocarcinoma (TCGA): 1.71e-5
Lung Adenocarcinoma (validation): 2.10e-4
Breast Invasive Carcinoma (validation): 3.89e-4
Kidney Chromophobe (TCGA): 6.42e-4
CKAP2LCytoskeleton associated protein 2 like
Liver Hepatocellular Carcinoma (validation): 8.29e-7
Pancreatic Adenocarcinoma (TCGA): 2.07e-5
Lung Adenocarcinoma (TCGA): 2.69e-5
Liver Hepatocellular Carcinoma (TCGA): 2.04e-4
Lung Adenocarcinoma (validation): 2.22e-4
Bladder Urothelial Carcinoma (TCGA): 2.32e-4
TMEM139Transmembrane protein 139
Kidney Renal Clear Cell Carcinoma (TCGA): 1.10e-9
Pancreatic Adenocarcinoma (TCGA): 2.27e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.95e-4
CTNND1Catenin delta 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.88e-9
Pancreatic Adenocarcinoma (TCGA): 2.33e-5
Kidney Renal Clear Cell Carcinoma (validation): 7.92e-5
ECT2Epithelial cell transforming 2
Lung Adenocarcinoma (TCGA): 2.34e-7
Kidney Renal Clear Cell Carcinoma (validation): 7.43e-7
Liver Hepatocellular Carcinoma (TCGA): 1.04e-6
Liver Hepatocellular Carcinoma (validation): 2.71e-6
Pancreatic Adenocarcinoma (TCGA): 2.41e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 8.89e-4
CCNB2Cyclin B2
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.05e-12
Kidney Renal Clear Cell Carcinoma (TCGA): 3.29e-9
Liver Hepatocellular Carcinoma (validation): 4.73e-8
Lung Adenocarcinoma (TCGA): 1.07e-5
Liver Hepatocellular Carcinoma (TCGA): 1.31e-5
Pancreatic Adenocarcinoma (TCGA): 2.47e-5
Kidney Chromophobe (TCGA): 4.17e-5
Kidney Renal Clear Cell Carcinoma (validation): 4.36e-5
Lung Adenocarcinoma (validation): 2.43e-4
SOBPSine oculis binding protein homolog
Pancreatic Adenocarcinoma (TCGA): 2.48e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.01e-4
SAV1Salvador family WW domain containing protein 1
Kidney Renal Clear Cell Carcinoma (TCGA): 2.28e-7
Kidney Renal Clear Cell Carcinoma (validation): 6.90e-6
Pancreatic Adenocarcinoma (TCGA): 2.52e-5
Lung Adenocarcinoma (validation): 2.67e-4
Breast Invasive Carcinoma (TCGA): 5.12e-4
Colon Adenocarcinoma (validation): 5.33e-4
DLGAP5DLG associated protein 5
Liver Hepatocellular Carcinoma (validation): 1.13e-10
Kidney Renal Clear Cell Carcinoma (TCGA): 1.79e-6
Liver Hepatocellular Carcinoma (TCGA): 5.96e-6
Lung Adenocarcinoma (TCGA): 1.53e-5
Pancreatic Adenocarcinoma (TCGA): 2.54e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.58e-4
HMGA2High mobility group AT-hook 2
Kidney Renal Clear Cell Carcinoma (TCGA): 6.34e-7
Pancreatic Adenocarcinoma (validation): 1.51e-6
Pancreatic Adenocarcinoma (TCGA): 2.59e-5
KLF3KLF transcription factor 3
Kidney Renal Clear Cell Carcinoma (TCGA): 5.81e-6
Pancreatic Adenocarcinoma (TCGA): 2.73e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.16e-4
SSRP1Structure specific recognition protein 1
Liver Hepatocellular Carcinoma (TCGA): 2.93e-7
Pancreatic Adenocarcinoma (TCGA): 2.79e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 3.68e-5
Lung Adenocarcinoma (validation): 5.40e-5
Liver Hepatocellular Carcinoma (validation): 2.38e-4
Lung Adenocarcinoma (TCGA): 2.49e-4
SLC2A8Solute carrier family 2 member 8
Kidney Renal Clear Cell Carcinoma (TCGA): 1.07e-6
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 1.00e-5
Pancreatic Adenocarcinoma (TCGA): 2.84e-5
Pancreatic Adenocarcinoma (validation): 2.94e-4
Thyroid Carcinoma (TCGA): 5.81e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.84e-4
EFNB2Ephrin B2
Kidney Renal Clear Cell Carcinoma (TCGA): 2.09e-10
Pancreatic Adenocarcinoma (TCGA): 2.85e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 1.36e-4
Kidney Renal Clear Cell Carcinoma (validation): 2.12e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 6.49e-4
RNF216Ring finger protein 216
Pancreatic Adenocarcinoma (TCGA): 2.90e-5
Liver Hepatocellular Carcinoma (validation): 2.27e-4
Liver Hepatocellular Carcinoma (TCGA): 3.14e-4
KIF20BKinesin family member 20B
Pancreatic Adenocarcinoma (TCGA): 3.02e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 4.48e-5
Pancreatic Adenocarcinoma (validation): 1.44e-4
Lung Adenocarcinoma (TCGA): 3.55e-4
FAM83DFamily with sequence similarity 83 member D
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.04e-11
Liver Hepatocellular Carcinoma (validation): 6.14e-7
Lung Adenocarcinoma (TCGA): 9.46e-6
Kidney Chromophobe (TCGA): 2.14e-5
Liver Hepatocellular Carcinoma (TCGA): 3.42e-5
Pancreatic Adenocarcinoma (TCGA): 3.68e-5
Lung Adenocarcinoma (validation): 5.02e-4
CFAP410Cilia and flagella associated protein 410
Pancreatic Adenocarcinoma (TCGA): 3.80e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.29e-5
Pancreatic Adenocarcinoma (validation): 1.23e-4
TMOD3Tropomodulin 3
Kidney Renal Clear Cell Carcinoma (TCGA): 3.30e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.76e-5
Pancreatic Adenocarcinoma (TCGA): 3.87e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 5.85e-5
GAREM1GRB2 associated regulator of MAPK1 subtype 1
Kidney Renal Clear Cell Carcinoma (TCGA): 3.14e-10
Pancreatic Adenocarcinoma (TCGA): 3.91e-5
Kidney Renal Clear Cell Carcinoma (validation): 3.98e-5
E2F1E2F transcription factor 1
Liver Hepatocellular Carcinoma (validation): 6.43e-7
Kidney Chromophobe (TCGA): 1.15e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.52e-5
Pancreatic Adenocarcinoma (TCGA): 3.91e-5
Liver Hepatocellular Carcinoma (TCGA): 1.10e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.49e-4
LYRM9LYR motif containing 9
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.08e-8
Kidney Renal Clear Cell Carcinoma (validation): 6.86e-6
Pancreatic Adenocarcinoma (TCGA): 4.13e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.15e-4
Lung Adenocarcinoma (TCGA): 8.81e-4
SSBP1Single stranded DNA binding protein 1
Liver Hepatocellular Carcinoma (TCGA): 2.98e-6
Pancreatic Adenocarcinoma (TCGA): 4.70e-5
Lung Adenocarcinoma (TCGA): 5.98e-5
Liver Hepatocellular Carcinoma (validation): 6.57e-4
CCNG2Cyclin G2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.01e-9
Kidney Renal Clear Cell Carcinoma (validation): 7.27e-6
Pancreatic Adenocarcinoma (TCGA): 5.00e-5
Rectum Adenocarcinoma (TCGA): 4.88e-4
ITGA2Integrin subunit alpha 2
Kidney Renal Clear Cell Carcinoma (TCGA): 5.37e-7
Pancreatic Adenocarcinoma (TCGA): 5.59e-5
Pancreatic Adenocarcinoma (validation): 7.65e-4
Kidney Renal Clear Cell Carcinoma (validation): 7.89e-4
Page of 44 | next ยป